Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2850 of 2873 entries
View as:

Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00480987 Org: User:
Start: 07/31/07 End: 08/31/10 Due: 08/31/11

Pharmacogenetics, Emotional Reactivity and Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00507728 Org: User:
Start: 12/08/05 End: 12/18/19 Due: 12/18/20

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Phase: N/A Priority: Normal
NCT ID: NCT00499889 Org: User:
Start: 02/28/03 End: 11/30/09 Due: 11/30/10

E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT01692197 Org: User:
Start: 02/01/13 End: 06/07/17 Due: 06/07/18

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01200342 Org: User:
Start: 12/31/10 End: 09/30/13 Due: 09/30/14

Transition From Research to Disclosure in Human Genetics

Phase: N/A Priority: Normal
NCT ID: NCT00505466 Org: User:
Start: 05/06/99 End: 02/08/22 Due: 02/08/23

Pemetrexed Plus Gemcitabine in Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00491075 Org: User:
Start: 12/31/05 End: 09/30/11 Due: 09/30/12

MATCh Parents' Supplemental Survey

Phase: N/A Priority: Normal
NCT ID: NCT00487357 Org: User:
Start: 06/30/06 End: 05/31/12 Due: 05/31/13

FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00381004 Org: User:
Start: 09/30/06 End: 12/31/14 Due: 12/31/15

Simultaneous Integrated Boost (SIB) in Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01102088 Org: User:
Start: 04/30/10 End: 06/08/19 Due: 06/08/20

Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00059345 Org: User:
Start: 09/30/02 End: 08/31/06 Due: 08/31/07

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03370718 Org: User:
Start: 02/26/18 End: 01/12/24 Due: 01/12/25

Correlating MicroRNA Changes With Sepsis Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03929159 Org: User:
Start: 03/26/19 End: 12/31/26 Due: 12/31/27

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05038839 Org: User:
Start: 02/09/22 End: 06/03/26 Due: 06/03/27

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01160354 Org: User:
Start: 08/31/10 End: 03/31/16 Due: 03/31/17

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04047641 Org: User:
Start: 10/22/19 End: 12/31/25 Due: 12/31/26

Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00459524 Org: User:
Start: 04/30/04 End: 03/31/09 Due: 03/31/10

Opiophobia in Postsurgical Adults With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06536283 Org: User:
Start: 09/16/24 End: 12/31/26 Due: 12/31/27

Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

Phase: N/A Priority: Normal
NCT ID: NCT06989099 Org: User:
Start: 09/24/24 End: 08/01/29 Due: 08/01/30

A Randomized Controlled Trial to Assess the Impact of Live and Recorded Music-Based Interventions on Pre-operative Stress, Mood, Pain and Biomarkers, in Neurosurgical Patients (Music-STAR Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06536504 Org: User:
Start: 12/19/24 End: 03/01/29 Due: 03/01/30

Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02394535 Org: User:
Start: 11/12/15 End: 08/31/22 Due: 08/31/23

BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05010096 Org: User:
Start: 03/22/22 End: 03/22/22 Due: 03/22/23

Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance

Phase: N/A Priority: Normal
NCT ID: NCT00421057 Org: User:
Start: 01/31/07 End: 03/31/09 Due: 03/31/10

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02754544 Org: User:
Start: 07/22/16 End: 01/01/28 Due: 01/01/29

Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00810576 Org: User:
Start: 01/31/09 End: 04/30/10 Due: 04/30/11